Chembio Diagnostics Stock Probability Of Bankruptcy
CEMIDelisted Stock | USD 0.46 0.01 2.22% |
Chembio |
Chembio Diagnostics Company probability of distress Analysis
Chembio Diagnostics' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Chembio Diagnostics Probability Of Bankruptcy | Over 100% |
Most of Chembio Diagnostics' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chembio Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Chembio Diagnostics probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Chembio Diagnostics odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Chembio Diagnostics financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Chembio Diagnostics has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the Health Care Equipment & Supplies sector and 144.86% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Chembio Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chembio Diagnostics' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chembio Diagnostics could also be used in its relative valuation, which is a method of valuing Chembio Diagnostics by comparing valuation metrics of similar companies.Chembio Diagnostics is currently under evaluation in probability of bankruptcy category among related companies.
Chembio Fundamentals
Return On Equity | -0.89 | |||
Return On Asset | -0.19 | |||
Profit Margin | (0.47) % | |||
Operating Margin | (0.41) % | |||
Current Valuation | 16.42 M | |||
Shares Outstanding | 36.73 M | |||
Shares Owned By Insiders | 2.39 % | |||
Shares Owned By Institutions | 21.60 % | |||
Number Of Shares Shorted | 292.14 K | |||
Price To Earning | (8.49) X | |||
Price To Book | 0.66 X | |||
Price To Sales | 0.19 X | |||
Revenue | 48.34 M | |||
Gross Profit | 3.88 M | |||
EBITDA | (14.61 M) | |||
Net Income | (23.29 M) | |||
Cash And Equivalents | 22.84 M | |||
Cash Per Share | 0.76 X | |||
Total Debt | 10.2 K | |||
Debt To Equity | 1.31 % | |||
Current Ratio | 2.91 X | |||
Book Value Per Share | 0.48 X | |||
Cash Flow From Operations | (12.69 M) | |||
Short Ratio | 0.36 X | |||
Earnings Per Share | (0.71) X | |||
Price To Earnings To Growth | (0.48) X | |||
Target Price | 8.0 | |||
Number Of Employees | 188 | |||
Beta | 1.86 | |||
Market Capitalization | 16.71 M | |||
Total Asset | 62.61 M | |||
Retained Earnings | (73.47 M) | |||
Working Capital | 9.48 M | |||
Current Asset | 12.63 M | |||
Current Liabilities | 3.15 M | |||
Net Asset | 62.61 M |
About Chembio Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chembio Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chembio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chembio Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chembio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chembio Diagnostics' short interest history, or implied volatility extrapolated from Chembio Diagnostics options trading.
Pair Trading with Chembio Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.Moving against Chembio Stock
0.58 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
0.52 | INTC | Intel Earnings Call Today | PairCorr |
0.5 | HPQ | HP Inc Financial Report 4th of June 2024 | PairCorr |
0.41 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Chembio Stock
If you are still planning to invest in Chembio Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chembio Diagnostics' history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |